According to the FDA briefing document, severe systemic reactions were 4× MORE COMMON than with the traditional flu shot. Data consistent with mRNA being a more dangerous vaccine platform. Will it sell in a crowded flu shot market?
Dj33p on Nostr: FDA Approves Moderna's mRNA Influenza Vaccine Despite 75.3% Rate of Adverse Reactions ...
FDA Approves Moderna's mRNA Influenza Vaccine Despite 75.3% Rate of Adverse Reactions
According to the FDA briefing document, severe systemic reactions were 4× MORE COMMON than with the traditional flu shot. Data consistent with mRNA being a more dangerous vaccine platform. Will it sell in a crowded flu shot market?
According to the FDA briefing document, severe systemic reactions were 4× MORE COMMON than with the traditional flu shot. Data consistent with mRNA being a more dangerous vaccine platform. Will it sell in a crowded flu shot market?